JP2014511848A5 - - Google Patents

Download PDF

Info

Publication number
JP2014511848A5
JP2014511848A5 JP2014502654A JP2014502654A JP2014511848A5 JP 2014511848 A5 JP2014511848 A5 JP 2014511848A5 JP 2014502654 A JP2014502654 A JP 2014502654A JP 2014502654 A JP2014502654 A JP 2014502654A JP 2014511848 A5 JP2014511848 A5 JP 2014511848A5
Authority
JP
Japan
Prior art keywords
alkyl
oxazepin
hydroxybenzamide
dibenzo
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014502654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014511848A (ja
JP5995956B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/030527 external-priority patent/WO2012135097A1/en
Publication of JP2014511848A publication Critical patent/JP2014511848A/ja
Publication of JP2014511848A5 publication Critical patent/JP2014511848A5/ja
Application granted granted Critical
Publication of JP5995956B2 publication Critical patent/JP5995956B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014502654A 2011-03-26 2012-03-26 前頭側頭葉変性症の標的治療の方法 Expired - Fee Related JP5995956B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161467989P 2011-03-26 2011-03-26
US61/467,989 2011-03-26
PCT/US2012/030527 WO2012135097A1 (en) 2011-03-26 2012-03-26 Methods of targeted treatment of frontotemporal lobar degeneration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016162758A Division JP2017019826A (ja) 2011-03-26 2016-08-23 前頭側頭葉変性症の標的治療の方法

Publications (3)

Publication Number Publication Date
JP2014511848A JP2014511848A (ja) 2014-05-19
JP2014511848A5 true JP2014511848A5 (https=) 2015-05-14
JP5995956B2 JP5995956B2 (ja) 2016-09-21

Family

ID=45931040

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014502654A Expired - Fee Related JP5995956B2 (ja) 2011-03-26 2012-03-26 前頭側頭葉変性症の標的治療の方法
JP2016162758A Pending JP2017019826A (ja) 2011-03-26 2016-08-23 前頭側頭葉変性症の標的治療の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016162758A Pending JP2017019826A (ja) 2011-03-26 2016-08-23 前頭側頭葉変性症の標的治療の方法

Country Status (13)

Country Link
US (1) US20140179678A1 (https=)
EP (1) EP2691099A1 (https=)
JP (2) JP5995956B2 (https=)
CN (2) CN103561747B (https=)
AR (1) AR085572A1 (https=)
AU (1) AU2012236852A1 (https=)
CA (1) CA2831291A1 (https=)
IL (1) IL228405A0 (https=)
MX (1) MX2013011096A (https=)
RU (1) RU2013147810A (https=)
TW (1) TW201247205A (https=)
UY (1) UY33973A (https=)
WO (1) WO2012135097A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10149836B2 (en) 2014-03-21 2018-12-11 The Board Of Regents Of The University Of Texas System Isoxazole treatments for frontotemporal dementia
US10189841B2 (en) 2015-11-20 2019-01-29 Forma Therapeutics, Inc. Purinones as ubiquitin-specific protease 1 inhibitors
AR119149A1 (es) * 2019-06-12 2021-11-24 Arkuda Therapeutics Derivados de isoquinolina como moduladores de la progranulina
US20230201269A1 (en) * 2020-04-24 2023-06-29 Spinalcyte, Llc Treatment of frontotemporal dementia using fibroblasts and products thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723564B2 (en) 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
CN101573333B (zh) * 2006-10-28 2013-06-12 梅特希尔基因公司 组蛋白脱乙酰酶抑制剂
US20090291444A1 (en) * 2008-03-31 2009-11-26 Jason Eriksen Methods and materials for detecting and treating dementia
US20110288070A1 (en) * 2008-05-05 2011-11-24 ROGERS Kathryn Methods for treating cognitive disorders using inhibitors of histone deacetylase
WO2009137499A1 (en) * 2008-05-05 2009-11-12 Envivo Pharmaceuticals, Inc. Inhibitors of histone deacetylase

Similar Documents

Publication Publication Date Title
JP2010508296A5 (https=)
RU2744988C2 (ru) Соединения и композиции для подавления активности shp2
WO2019183546A1 (en) Organic compounds
TW201444835A (zh) 用於治療發炎病症之新穎化合物及彼等之醫藥組合物
JP2009524676A5 (https=)
JP2019536768A5 (https=)
US20150080404A1 (en) Novel compositions and methods
CA2628131A1 (en) Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
JP2017536409A5 (https=)
JP2007512299A5 (https=)
WO2005079807A1 (en) Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
JP2017513887A5 (https=)
JP2004517070A5 (https=)
JP2014511848A5 (https=)
JP2010504352A5 (https=)
JP2005508969A5 (https=)
JP2002532503A5 (https=)
WO2010000030A1 (en) Thiazopyrimidinones and uses thereof
RU2013147810A (ru) Способы целенаправленного лечения лобно-височной лобарной дегенерации
WO2024130065A1 (en) Substituted dihydropyrrolo[3, 4-d]pyrimidine compounds and their use in treating medical conditions
WO2024130066A1 (en) Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditions
JP2017534652A5 (https=)
RU2014105177A (ru) Новое соединение, проявляющее ингибиторную активность в отношении parp
KR20080107429A (ko) 정신병적 장애의 치료 또는 예방용의 신규한 치료학적 배합물
RU2007112675A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1,5-a]ТРИАЗОЛО[1,5-d]БЕНЗОДИАЗЕПИНА ДЛЯ ЛЕЧЕНИЯ КОГНИТИВНЫХ РАССТРОЙСТВ